{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:24:44Z","timestamp":1774416284240,"version":"3.50.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40120-020-00202-7","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T22:02:28Z","timestamp":1594764148000},"page":"281-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis"],"prefix":"10.1007","volume":"9","author":[{"given":"Mar\u00eda Jos\u00e9","family":"S\u00e1","sequence":"first","affiliation":[]},{"given":"Ricardo","family":"Soares dos Reis","sequence":"additional","affiliation":[]},{"given":"Ayse","family":"Altintas","sequence":"additional","affiliation":[]},{"given":"Elisabeth Gulowsen","family":"Celius","sequence":"additional","affiliation":[]},{"given":"Claudia","family":"Chien","sequence":"additional","affiliation":[]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[]},{"given":"Jeremy","family":"Hobart","sequence":"additional","affiliation":[]},{"given":"Gulfaraz","family":"Khan","sequence":"additional","affiliation":[]},{"given":"Najib","family":"Kissani","sequence":"additional","affiliation":[]},{"given":"Dawn","family":"Langdon","sequence":"additional","affiliation":[]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Darin T.","family":"Okuda","sequence":"additional","affiliation":[]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[]},{"given":"Regina Mar\u00eda","family":"Papais-Alvarenga","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Mendes-Pinto","sequence":"additional","affiliation":[]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"202_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"6736","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018;6736:1\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1.","journal-title":"Lancet"},{"key":"202_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"key":"202_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","volume":"27","author":"R Dutta","year":"2014","unstructured":"Dutta R, Trapp BD. Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol. 2014;27:271\u20138. https:\/\/doi.org\/10.1097\/WCO.0000000000000094.","journal-title":"Curr Opin Neurol"},{"key":"202_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti S, Fransen NL, van Eden CG, et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol. 2018;135:511\u201328. https:\/\/doi.org\/10.1007\/s00401-018-1818-y.","journal-title":"Acta Neuropathol"},{"key":"202_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer JM, Weigand SD, Guo Y, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015;78:710\u201321. https:\/\/doi.org\/10.1002\/ana.24497.","journal-title":"Ann Neurol"},{"key":"202_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","volume":"8","author":"H Lassmann","year":"2012","unstructured":"Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8:647\u201356. https:\/\/doi.org\/10.1038\/nrneurol.2012.168.","journal-title":"Nat Rev Neurol"},{"key":"202_CR7","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128:2705\u201312. https:\/\/doi.org\/10.1093\/brain\/awh641.","journal-title":"Brain"},{"issue":"Suppl 1","key":"202_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000367614","volume":"72","author":"FD Lublin","year":"2014","unstructured":"Lublin FD. New multiple sclerosis phenotypic classification. Eur Neurol. 2014;72(Suppl 1):1\u20135. https:\/\/doi.org\/10.1159\/000367614.","journal-title":"Eur Neurol"},{"key":"202_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14:577\u201389. https:\/\/doi.org\/10.1038\/s41582-018-0058-z.","journal-title":"Nat Rev Neurol"},{"key":"202_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/11539590-000000000-00000","volume":"25","author":"T Robak","year":"2011","unstructured":"Robak T, Robak E. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies. BioDrugs. 2011;25:13\u201325. https:\/\/doi.org\/10.2165\/11539590-000000000-00000.","journal-title":"BioDrugs"},{"key":"202_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1476-5381.2012.02061.x","volume":"167","author":"P Gergely","year":"2012","unstructured":"Gergely P, Nuesslein-Hildesheim B, Guerini D, et al. The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate. Br J Pharmacol. 2012;167:1035\u201347. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02061.x.","journal-title":"Br J Pharmacol"},{"key":"202_CR12","unstructured":"Multiple Sclerosis International Federation. Atlas of multiple sclerosis 2013\u2014mapping multiple sclerosis around the world. 2013. https:\/\/www.msif.org\/wp-content\/uploads\/2014\/09\/Atlas-of-MS.pdf. Accessed 15 May 2019."},{"key":"202_CR13","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1097\/MD.0000000000012856","volume":"97","author":"\u00dcT B\u00f6r\u00fc","year":"2018","unstructured":"B\u00f6r\u00fc \u00dcT, Duman A, Kulualp AS, et al. Multiple sclerosis prevalence study. Medicine (Baltimore). 2018;97:e12856.","journal-title":"Medicine (Baltimore)"},{"key":"202_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5152\/npa.2016.12451","volume":"54","author":"N Akdemir","year":"2017","unstructured":"Akdemir N, Terzi M, Arslan N, et al. Prevalence of multiple sclerosis in the middle black sea region of Turkey and demographic characteristics of patients. Arch Neuropsychiatry. 2017;54:11\u20134. https:\/\/doi.org\/10.5152\/npa.2016.12451.","journal-title":"Arch Neuropsychiatry"},{"key":"202_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000334316","volume":"37","author":"\u00dcT B\u00f6r\u00fc","year":"2011","unstructured":"B\u00f6r\u00fc \u00dcT, Ta\u015fdemir M, G\u00fcler N, et al. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal black sea regions of Turkey. Neuroepidemiology. 2011;37:231\u20135. https:\/\/doi.org\/10.1159\/000334316.","journal-title":"Neuroepidemiology"},{"key":"202_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000093895","volume":"27","author":"\u00dcT B\u00f6r\u00fc","year":"2006","unstructured":"B\u00f6r\u00fc \u00dcT, Alp R, Sur H, et al. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology. 2006;27:17\u2013211. https:\/\/doi.org\/10.1159\/000093895.","journal-title":"Neuroepidemiology"},{"key":"202_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jns.2014.08.008","volume":"346","author":"E Ait Ben Haddou","year":"2014","unstructured":"Ait Ben Haddou E, Alhyan M, Aasfara J, et al. Multiple sclerosis: clinical characteristics and disability progression in Moroccan children. J Neurol Sci. 2014;346:128\u201332. https:\/\/doi.org\/10.1016\/j.jns.2014.08.008.","journal-title":"J Neurol Sci"},{"key":"202_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/1352458513506504","volume":"20","author":"A Araqi-Houssaini","year":"2014","unstructured":"Araqi-Houssaini A, Lahlou I, Benkadmir Y, et al. Multiple sclerosis severity score in a cohort of Moroccan patients. Mult Scler. 2014;20:764\u20135. https:\/\/doi.org\/10.1177\/1352458513506504.","journal-title":"Mult Scler"},{"key":"202_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/WNL.0000000000003762","volume":"88","author":"Y Sidhom","year":"2017","unstructured":"Sidhom Y, Maillart E, du Montcel ST, et al. Fast multiple sclerosis progression in North Africans\u2014both genetics and environment matter. Neurology. 2017;88:1218\u201325.","journal-title":"Neurology"},{"key":"202_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"J Bennett","year":"2015","unstructured":"Bennett J, de Seze J, Lana-Peixoto M, et al. Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Mult Scler J. 2015;21:678\u201388. https:\/\/doi.org\/10.1177\/1352458514567216.","journal-title":"Mult Scler J"},{"key":"202_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1212\/WNL.0b013e3182a1aac7","volume":"81","author":"C-S Yang","year":"2013","unstructured":"Yang C-S, Yang L, Li T, et al. Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica. Neurology. 2013;81:710\u20133.","journal-title":"Neurology"},{"key":"202_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/jamaneurol.2017.1336","volume":"74","author":"C Zhang","year":"2017","unstructured":"Zhang C, Tian D, Yang C, et al. Safety and efficacy of bortezomib in patients with highly relapsing neuromyelitis optica spectrum disorder. JAMA Neurol. 2017;74:1010\u20132.","journal-title":"JAMA Neurol"},{"key":"202_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/1352458512462918","volume":"19","author":"E Cristiano","year":"2013","unstructured":"Cristiano E, Romano M, Frider N, et al. The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review. Mult Scler J. 2013;19:844\u201354. https:\/\/doi.org\/10.1177\/1352458512462918.","journal-title":"Mult Scler J"},{"key":"202_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.msard.2015.08.004","volume":"4","author":"A Beatriz","year":"2015","unstructured":"Beatriz A, Nogueira C, Clinete M, et al. Prevalence of multiple sclerosis in Brazil: a systematic review. Mult Scler Relat Disord. 2015;4:572\u20139. https:\/\/doi.org\/10.1016\/j.msard.2015.08.004.","journal-title":"Mult Scler Relat Disord"},{"key":"202_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s100720170011","volume":"22","author":"G Rosati","year":"2001","unstructured":"Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117\u201339.","journal-title":"Neurol Sci"},{"key":"202_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/ane.12431","volume":"132","author":"J Correale","year":"2015","unstructured":"Correale J, Gait\u00e1n MI. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein\u2013Barr virus infection. Acta Neurol Scand. 2015;132:46\u201355. https:\/\/doi.org\/10.1111\/ane.12431.","journal-title":"Acta Neurol Scand"},{"key":"202_CR27","doi-asserted-by":"publisher","first-page":"e0127757","DOI":"10.1371\/journal.pone.0127757","volume":"10","author":"RM Papais-Alvarenga","year":"2015","unstructured":"Papais-Alvarenga RM, Vasconcelos CCF, Carra A, et al. Central nervous system idiopathic inflammatory demyelinating disorders in South Americans: a descriptive, multicenter, cross-sectional study. PLoS ONE. 2015;10:e0127757. https:\/\/doi.org\/10.1371\/journal.pone.0127757.","journal-title":"PLoS ONE"},{"key":"202_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ane.12425","volume":"132","author":"J Hillert","year":"2015","unstructured":"Hillert J, Stawiarz L. The Swedish MS registry\u2014clinical support tool and scientific resource. Acta Neurol Scand. 2015;132:11\u20139. https:\/\/doi.org\/10.1111\/ane.12425.","journal-title":"Acta Neurol Scand"},{"key":"202_CR29","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1177\/1352458516681197","volume":"23","author":"A Manouchehrinia","year":"2017","unstructured":"Manouchehrinia A, Beiki O, Hillert J. Clinical course of multiple sclerosis: a nationwide cohort study. Mult Scler. 2017;23:1488\u201395. https:\/\/doi.org\/10.1177\/1352458516681197.","journal-title":"Mult Scler"},{"key":"202_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/https","volume":"24","author":"H Gyllensten","year":"2018","unstructured":"Gyllensten H, Wiberg M, Alexanderson K, et al. Comparing costs of illness of multiple sclerosis in three different years: a population-based study. Mult Scler J. 2018;24:520\u20138. https:\/\/doi.org\/10.1177\/https.","journal-title":"Mult Scler J"},{"key":"202_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/1352458516643394","volume":"22","author":"H Westerlind","year":"2016","unstructured":"Westerlind H, Stawiarz L, Fink K, et al. A significant decrease in diagnosis of primary progressive multiple sclerosis: a cohort study. Mult Scler J. 2016;22:1071\u20139. https:\/\/doi.org\/10.1177\/1352458516643394.","journal-title":"Mult Scler J"},{"key":"202_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518783667","author":"A Manouchehrinia","year":"2018","unstructured":"Manouchehrinia A, Zhu F, Piani-meier D, et al. Predicting risk of secondary progression in multiple sclerosis: a nomogram. Mult Scler J. 2018. https:\/\/doi.org\/10.1177\/1352458518783667.","journal-title":"Mult Scler J"},{"key":"202_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/2055217318783352","author":"H Gyllensten","year":"2018","unstructured":"Gyllensten H, Kavaliunas A, Alexanderson K, et al. Costs and quality of life by disability among people with multiple sclerosis: a register-based study in Sweden. Mult Scler J Exp Transl Clin. 2018. https:\/\/doi.org\/10.1177\/2055217318783352.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"202_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/1352458512463764","volume":"19","author":"H Tedeholm","year":"2012","unstructured":"Tedeholm H, Lycke J, Skoog B, et al. Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler J. 2012;19:765\u201374. https:\/\/doi.org\/10.1177\/1352458512463764.","journal-title":"Mult Scler J"},{"key":"202_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/1352458516675039","volume":"23","author":"A Kavaliunas","year":"2017","unstructured":"Kavaliunas A, Manouchehrinia A, Stawiarz L, et al. Importance of early treatment initiation in the clinical course of multiple sclerosis. Mult Scler J. 2017;23:1233\u201340. https:\/\/doi.org\/10.1177\/1352458516675039.","journal-title":"Mult Scler J"},{"key":"202_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00415-018-8764-4","volume":"265","author":"E Landfeldt","year":"2018","unstructured":"Landfeldt E, Castelo A, Axel B, et al. The long-term impact of early treatment of multiple sclerosis on the risk of disability pension. J Neurol. 2018;265:701\u20137. https:\/\/doi.org\/10.1007\/s00415-018-8764-4.","journal-title":"J Neurol"},{"key":"202_CR37","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jamaneurol.2015.1788","volume":"72","author":"R Ramanujam","year":"2015","unstructured":"Ramanujam R, Hedstr\u00f6m A-K, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol. 2015;72:1117\u201323. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1788.","journal-title":"JAMA Neurol"},{"key":"202_CR38","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee WJ, Hardy TA, Fazekas F, et al. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389:1336\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(16)30959-X.","journal-title":"Lancet"},{"key":"202_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR. \u2018Limbic encephalitis\u2019 and its association with carcinoma. Brain. 1968;91:481\u201396.","journal-title":"Brain"},{"key":"202_CR40","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840\u201351. https:\/\/doi.org\/10.1056\/NEJMra1708712.","journal-title":"N Engl J Med"},{"key":"202_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"202_CR42","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17:760\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(18)30244-8.","journal-title":"Lancet Neurol"},{"key":"202_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, et al. Anti-LGI1\u2013associated cognitive impairment Presentation and long-term outcome. Neurology. 2016;87:759\u201365.","journal-title":"Neurology"},{"key":"202_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo II, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"202_CR45","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140:3128\u201338. https:\/\/doi.org\/10.1093\/brain\/awx276.","journal-title":"Brain"},{"key":"202_CR46","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults\u2014the MOGADOR study. Neurology. 2018;90:e1858\u2013e18691869. https:\/\/doi.org\/10.1212\/WNL.0000000000005560.","journal-title":"Neurology"},{"key":"202_CR47","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","volume":"80","author":"L Matthews","year":"2013","unstructured":"Matthews L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013;80:1330\u20137.","journal-title":"Neurology"},{"key":"202_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2017-001787","author":"M Jury\u0144czyk","year":"2018","unstructured":"Jury\u0144czyk M, Jacob A, Fujihara K, et al. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations. Pract Neurol. 2018. https:\/\/doi.org\/10.1136\/practneurol-2017-001787.","journal-title":"Pract Neurol"},{"key":"202_CR49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C, et al. Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol. 2018;75:478\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4601.","journal-title":"JAMA Neurol"},{"key":"202_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg psychiatry. 2018;89:127\u201337. https:\/\/doi.org\/10.1136\/jnnp-2017-316880.","journal-title":"J Neurol Neurosurg psychiatry"},{"key":"202_CR51","doi-asserted-by":"crossref","unstructured":"Giovannoni G, Butzkueven H, Dhib-Jalbut S et al. Brain health\u2014time matters in multiple sclerosis. 2015. https:\/\/www.msbrainhealth.org\/perch\/resources\/brain-health-time-matters-in-multiple-sclerosis-sep-17-2.pdf. Accessed 15 May 2019.","DOI":"10.21305\/MSBH.001"},{"key":"202_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518809326","author":"J Hobart","year":"2018","unstructured":"Hobart J, Bowen A, Pepper G, et al. International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler. 2018. https:\/\/doi.org\/10.1177\/1352458518809326.","journal-title":"Mult Scler"},{"key":"202_CR53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/WCO.0b013e328346a43b","volume":"24","author":"DW Langdon","year":"2011","unstructured":"Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol. 2011;24:244\u20139. https:\/\/doi.org\/10.1097\/WCO.0b013e328346a43b.","journal-title":"Curr Opin Neurol"},{"key":"202_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11940-018-0538-x","volume":"20","author":"AA Sokolov","year":"2018","unstructured":"Sokolov AA, Grivaz P, Bove R. Cognitive deficits in multiple sclerosis: recent advances in treatment and neurorehabilitation. Curr Treat Options Neurol. 2018;20:53. https:\/\/doi.org\/10.1007\/s11940-018-0538-x.","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"202_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/1352458518769837","volume":"25","author":"G Kobelt","year":"2019","unstructured":"Kobelt G, Langdon D, Jonsson L. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis. Mult Scler. 2019; 25(5):740\u20139. https:\/\/doi.org\/10.1177\/1352458518769837.","journal-title":"Mult Scler"},{"key":"202_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1352458517740212","volume":"25","author":"A Kavaliunas","year":"2019","unstructured":"Kavaliunas A, Danylaite Karrenbauer V, Gyllensten H, et al. Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability. Mult Scler. 2019;25:104\u201312. https:\/\/doi.org\/10.1177\/1352458517740212.","journal-title":"Mult Scler"},{"key":"202_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1352458509350311","volume":"16","author":"V Zipoli","year":"2010","unstructured":"Zipoli V, Goretti B, Hakiki B, et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler. 2010;16:62\u20137. https:\/\/doi.org\/10.1177\/1352458509350311.","journal-title":"Mult Scler"},{"key":"202_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/1352458510362819","volume":"16","author":"M Deloire","year":"2010","unstructured":"Deloire M, Ruet A, Hamel D, et al. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler. 2010;16:581\u20137. https:\/\/doi.org\/10.1177\/1352458510362819.","journal-title":"Mult Scler"},{"key":"202_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/1352458515599075","volume":"22","author":"M Moccia","year":"2016","unstructured":"Moccia M, Lanzillo R, Palladino R, et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler. 2016;22:659\u201367. https:\/\/doi.org\/10.1177\/1352458515599075.","journal-title":"Mult Scler"},{"key":"202_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10865-010-9247-y","volume":"33","author":"JM Bruce","year":"2010","unstructured":"Bruce JM, Hancock LM, Arnett P, et al. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med. 2010;33:219\u201327. https:\/\/doi.org\/10.1007\/s10865-010-9247-y.","journal-title":"J Behav Med"},{"key":"202_CR61","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jnnp-2014-308169","volume":"86","author":"N Muhlert","year":"2015","unstructured":"Muhlert N, Sethi V, Cipolotti L, et al. The grey matter correlates of impaired decision-making in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:530\u20136. https:\/\/doi.org\/10.1136\/jnnp-2014-308169.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"202_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12883-015-0318-0","volume":"15","author":"AD Radomski","year":"2015","unstructured":"Radomski AD, Power C, Purdon SE, et al. Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability. BMC Neurol. 2015;15:61. https:\/\/doi.org\/10.1186\/s12883-015-0318-0.","journal-title":"BMC Neurol"},{"key":"202_CR63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1352458508098599","volume":"15","author":"L Vahter","year":"2009","unstructured":"Vahter L, Zopp I, Kreegipuu M, et al. Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler. 2009;15:379\u201384. https:\/\/doi.org\/10.1177\/1352458508098599.","journal-title":"Mult Scler"},{"key":"202_CR64","doi-asserted-by":"publisher","first-page":"281760","DOI":"10.1155\/2014\/281760","volume":"2014","author":"A Kalron","year":"2014","unstructured":"Kalron A. The relationship between specific cognitive domains, fear of falling, and falls in people with multiple sclerosis. Biomed Res Int. 2014;2014:281760. https:\/\/doi.org\/10.1155\/2014\/281760.","journal-title":"Biomed Res Int"},{"key":"202_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/NRE-151246","volume":"37","author":"R van Vliet","year":"2015","unstructured":"van Vliet R, Hoang P, Lord S, et al. Multiple sclerosis severity and concern about falling: physical, cognitive and psychological mediating factors. NeuroRehabilitation. 2015;37:139\u201347. https:\/\/doi.org\/10.3233\/NRE-151246.","journal-title":"NeuroRehabilitation"},{"key":"202_CR66","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ptj\/pzx044","volume":"97","author":"H Khalil","year":"2017","unstructured":"Khalil H, Al-Shorman A, El-Salem K, et al. Fear of falling in people with multiple sclerosis: which clinical characteristics are important? Phys Ther. 2017;97:698\u2013706. https:\/\/doi.org\/10.1093\/ptj\/pzx044.","journal-title":"Phys Ther"},{"key":"202_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2012.02.003","volume":"316","author":"VL D\u2019Orio","year":"2012","unstructured":"D\u2019Orio VL, Foley FW, Armentano F, et al. Cognitive and motor functioning in patients with multiple sclerosis: neuropsychological predictors of walking speed and falls. J Neurol Sci. 2012;316:42\u20136. https:\/\/doi.org\/10.1016\/j.jns.2012.02.003.","journal-title":"J Neurol Sci"},{"key":"202_CR68","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.apmr.2013.02.009","volume":"94","author":"JJ Sosnoff","year":"2013","unstructured":"Sosnoff JJ, Balantrapu S, Pilutti LA, et al. Cognitive processing speed is related to fall frequency in older adults with multiple sclerosis. Arch Phys Med Rehabil. 2013;94:1567\u201372. https:\/\/doi.org\/10.1016\/j.apmr.2013.02.009.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2522\/ptj.20120231","volume":"93","author":"HJ Gunn","year":"2013","unstructured":"Gunn HJ, Newell P, Haas B, et al. Identification of risk factors for falls in multiple sclerosis: a systematic review and meta-analysis. Phys Ther. 2013;93:504\u201313. https:\/\/doi.org\/10.2522\/ptj.20120231.","journal-title":"Phys Ther"},{"key":"202_CR70","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apmr.2014.12.011","volume":"96","author":"DA Wajda","year":"2015","unstructured":"Wajda DA, Moon Y, Motl RW, et al. Preliminary investigation of gait initiation and falls in multiple sclerosis. Arch Phys Med Rehabil. 2015;96:1098\u2013102. https:\/\/doi.org\/10.1016\/j.apmr.2014.12.011.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0269215516637201","volume":"31","author":"Y Etemadi","year":"2017","unstructured":"Etemadi Y. Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: a prospective study. Clin Rehabil. 2017;31:278\u201384. https:\/\/doi.org\/10.1177\/0269215516637201.","journal-title":"Clin Rehabil"},{"key":"202_CR72","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.apmr.2009.09.026","volume":"91","author":"MT Schultheis","year":"2010","unstructured":"Schultheis MT, Weisser V, Ang J, et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2010;91:465\u201373. https:\/\/doi.org\/10.1016\/j.apmr.2009.09.026.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR73","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.apmr.2007.12.049","volume":"89","author":"TD Marcotte","year":"2008","unstructured":"Marcotte TD, Rosenthal TJ, Roberts E, et al. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2008;89:1753\u20138. https:\/\/doi.org\/10.1016\/j.apmr.2007.12.049.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR74","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1017\/S1355617714000368","volume":"20","author":"D Badenes","year":"2014","unstructured":"Badenes D, Garolera M, Casas L, et al. Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis. J Int Neuropsychol Soc. 2014;20:555\u201365. https:\/\/doi.org\/10.1017\/S1355617714000368.","journal-title":"J Int Neuropsychol Soc"},{"key":"202_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jns.2015.10.039","volume":"359","author":"D Lamargue-Hamel","year":"2015","unstructured":"Lamargue-Hamel D, Deloire M, Saubusse A, et al. Cognitive evaluation by tasks in a virtual reality environment in multiple sclerosis. J Neurol Sci. 2015;359:94\u20139. https:\/\/doi.org\/10.1016\/j.jns.2015.10.039.","journal-title":"J Neurol Sci"},{"key":"202_CR76","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1177\/1352458516633517","volume":"22","author":"RH Benedict","year":"2016","unstructured":"Benedict RH, Drake AS, Irwin LN, et al. Benchmarks of meaningful impairment on the MSFC and BICAMS. Mult Scler. 2016;22:1874\u201382. https:\/\/doi.org\/10.1177\/1352458516633517.","journal-title":"Mult Scler"},{"key":"202_CR77","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jns.2016.01.002","volume":"361","author":"J Hanna","year":"2016","unstructured":"Hanna J, Feinstein A, Morrow SA. The association of pathological laughing and crying and cognitive impairment in multiple sclerosis. J Neurol Sci. 2016;361:200\u20133. https:\/\/doi.org\/10.1016\/j.jns.2016.01.002.","journal-title":"J Neurol Sci"},{"key":"202_CR78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.neuropsych.15070167","volume":"28","author":"SA Morrow","year":"2016","unstructured":"Morrow SA, Rosehart H, Pantazopoulos K, et al. Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS. J Neuropsychiatry Clin Neurosci. 2016;28:118\u201323. https:\/\/doi.org\/10.1176\/appi.neuropsych.15070167.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"202_CR79","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.apmr.2016.05.003","volume":"97","author":"Y Goverover","year":"2016","unstructured":"Goverover Y, Haas S, DeLuca J. Money management activities in persons with multiple sclerosis. Arch Phys Med Rehabil. 2016;97:1901\u20137. https:\/\/doi.org\/10.1016\/j.apmr.2016.05.003.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR80","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/arclin\/acx039","volume":"32","author":"A Gerstenecker","year":"2017","unstructured":"Gerstenecker A, Myers T, Lowry K, et al. Financial capacity and its cognitive predictors in progressive multiple sclerosis. Arch Clin Neuropsychol. 2017;32:943\u201350. https:\/\/doi.org\/10.1093\/arclin\/acx039.","journal-title":"Arch Clin Neuropsychol"},{"key":"202_CR81","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3109\/09638288.2014.887797","volume":"36","author":"EBA Shevil","year":"2014","unstructured":"Shevil EBA, Johansson S, Ytterberg C, et al. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis? Disabil Rehabil. 2014;36:2012\u20138. https:\/\/doi.org\/10.3109\/09638288.2014.887797.","journal-title":"Disabil Rehabil"},{"key":"202_CR82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.dhjo.2007.11.001","volume":"1","author":"EA Vanner","year":"2008","unstructured":"Vanner EA, Block P, Christodoulou CC, et al. Pilot study exploring quality of life and barriers to leisure-time physical activity in persons with moderate to severe multiple sclerosis. Disabil Health J. 2008;1:58\u2013655. https:\/\/doi.org\/10.1016\/j.dhjo.2007.11.001.","journal-title":"Disabil Health J"},{"key":"202_CR83","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.apmr.2017.02.015","volume":"98","author":"D Cattaneo","year":"2017","unstructured":"Cattaneo D, Lamers I, Bertoni R, et al. Participation restriction in people with multiple sclerosis: prevalence and correlations with cognitive, walking, balance, and upper limb impairments. Arch Phys Med Rehabil. 2017;98:1308\u201315. https:\/\/doi.org\/10.1016\/j.apmr.2017.02.015.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR84","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.apmr.2015.07.003","volume":"96","author":"AJ Hughes","year":"2015","unstructured":"Hughes AJ, Hartoonian N, Parmenter B, et al. Cognitive impairment and community integration outcomes in individuals living with multiple sclerosis. Arch Phys Med Rehabil. 2015;96:1973\u20139. https:\/\/doi.org\/10.1016\/j.apmr.2015.07.003.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR85","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.2015.014332","author":"Y Goverover","year":"2015","unstructured":"Goverover Y, Strober L, Chiaravalloti N, et al. Factors that moderate activity limitation and participation restriction in people with multiple sclerosis. Am J Occup Ther. 2015. https:\/\/doi.org\/10.5014\/ajot.2015.014332.","journal-title":"Am J Occup Ther"},{"key":"202_CR86","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S1355617716001156","volume":"23","author":"MA Chalah","year":"2017","unstructured":"Chalah MA, Ayache SS. Deficits in social cognition: an unveiled signature of multiple sclerosis. J Int Neuropsychol Soc. 2017;23:266\u201386. https:\/\/doi.org\/10.1017\/S1355617716001156.","journal-title":"J Int Neuropsychol Soc"},{"key":"202_CR87","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00415-017-8417-z","volume":"264","author":"C Dulau","year":"2017","unstructured":"Dulau C, Deloire M, Diaz H, et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol. 2017;264:740\u20138. https:\/\/doi.org\/10.1007\/s00415-017-8417-z.","journal-title":"J Neurol"},{"key":"202_CR88","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/1352458514532398","volume":"20","author":"A Labiano-Fontcuberta","year":"2014","unstructured":"Labiano-Fontcuberta A, Mitchell AJ, Moreno-Garcia S, et al. Cognitive impairment in patients with multiple sclerosis predicts worse caregiver\u2019s health-related quality of life. Mult Scler. 2014;20:1769\u201379. https:\/\/doi.org\/10.1177\/1352458514532398.","journal-title":"Mult Scler"},{"key":"202_CR89","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jns.2015.01.024","volume":"349","author":"A Labiano-Fontcuberta","year":"2015","unstructured":"Labiano-Fontcuberta A, Mitchell AJ, Moreno-Garcia S, et al. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: the role of information processing speed impairment. J Neurol Sci. 2015;349:220\u20135. https:\/\/doi.org\/10.1016\/j.jns.2015.01.024.","journal-title":"J Neurol Sci"},{"key":"202_CR90","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1191\/1352458503ms861oa","volume":"9","author":"RHB Benedict","year":"2003","unstructured":"Benedict RHB, Munschauer F, Linn R, et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003;9:95\u2013101. https:\/\/doi.org\/10.1191\/1352458503ms861oa.","journal-title":"Mult Scler"},{"key":"202_CR91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/WNN.0b013e31822a20ae","volume":"24","author":"N Akbar","year":"2011","unstructured":"Akbar N, Honarmand K, Feinstein A. Self-assessment of cognition in multiple sclerosis: the role of personality and anxiety. Cogn Behav Neurol. 2011;24:115\u201321. https:\/\/doi.org\/10.1097\/WNN.0b013e31822a20ae.","journal-title":"Cogn Behav Neurol"},{"key":"202_CR92","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1037\/rep0000045","volume":"60","author":"M Beier","year":"2015","unstructured":"Beier M, Amtmann D, Ehde DM. Beyond depression: Predictors of self-reported cognitive function in adults living with MS. Rehabil Psychol. 2015;60:254\u201362. https:\/\/doi.org\/10.1037\/rep0000045.","journal-title":"Rehabil Psychol"},{"key":"202_CR93","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.apmr.2015.01.008","volume":"96","author":"AJ Hughes","year":"2015","unstructured":"Hughes AJ, Beier M, Hartoonian N, et al. Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis. Arch Phys Med Rehabil. 2015;96:913\u20139. https:\/\/doi.org\/10.1016\/j.apmr.2015.01.008.","journal-title":"Arch Phys Med Rehabil"},{"key":"202_CR94","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler. 2012;18:891\u20138. https:\/\/doi.org\/10.1177\/1352458511431076.","journal-title":"Mult Scler"},{"key":"202_CR95","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","volume":"91","author":"S-H Kim","year":"2018","unstructured":"Kim S-H, Mealy MA, Levy M, et al. Racial differences in neuromyelitis optica spectrum disorder. Neurology. 2018;91:e2089\u2013e20992099. https:\/\/doi.org\/10.1212\/WNL.0000000000006574.","journal-title":"Neurology"},{"key":"202_CR96","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","volume":"78","author":"B Bourre","year":"2012","unstructured":"Bourre B, Marignier R, Z\u00e9phir H, et al. Neuromyelitis optica and pregnancy. Neurology. 2012;78:875\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e31824c466f.","journal-title":"Neurology"},{"key":"202_CR97","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/brain\/awh152","volume":"127","author":"S Vukusic","year":"2004","unstructured":"Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004;127:1353\u201360. https:\/\/doi.org\/10.1093\/brain\/awh152.","journal-title":"Brain"},{"key":"202_CR98","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","volume":"78","author":"W Kim","year":"2012","unstructured":"Kim W, Kim S-H, Nakashima I, et al. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology. 2012;78:1264\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318250d812.","journal-title":"Neurology"},{"key":"202_CR99","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/1352458515583376","volume":"22","author":"Y Shimizu","year":"2016","unstructured":"Shimizu Y, Fujihara K, Ohashi T, et al. Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler. 2016;22:1413\u201320. https:\/\/doi.org\/10.1177\/1352458515583376.","journal-title":"Mult Scler"},{"key":"202_CR100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","volume":"86","author":"MM Nour","year":"2016","unstructured":"Nour MM, Coutinho E, George J, et al. Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology. 2016;86:79\u2013877. https:\/\/doi.org\/10.1212\/WNL.0000000000002208.","journal-title":"Neurology"},{"key":"202_CR101","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1212\/WNL.0000000000006384","volume":"91","author":"MK Houtchens","year":"2018","unstructured":"Houtchens MK, Edwards NC, Schneider G, et al. Pregnancy rates and outcomes in women with and without MS in the United States. Neurology. 2018;91:e1559\u2013e15691569. https:\/\/doi.org\/10.1212\/WNL.0000000000006384.","journal-title":"Neurology"},{"key":"202_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJM199807303390501","volume":"339","author":"C Confavreux","year":"1998","unstructured":"Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339:285\u201391. https:\/\/doi.org\/10.1056\/NEJM199807303390501.","journal-title":"N Engl J Med"},{"key":"202_CR103","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518816614","author":"G Bsteh","year":"2018","unstructured":"Bsteh G, Algrang L, Hegen H, et al. Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria. Mult Scler. 2018. https:\/\/doi.org\/10.1177\/1352458518816614.","journal-title":"Mult Scler"},{"key":"202_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.msard.2019.01.003","volume":"28","author":"A-L Nguyen","year":"2019","unstructured":"Nguyen A-L, Havrdova EK, Horakova D, et al. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study. Mult Scler Relat Disord. 2019;28:235\u201343. https:\/\/doi.org\/10.1016\/j.msard.2019.01.003.","journal-title":"Mult Scler Relat Disord"},{"key":"202_CR105","doi-asserted-by":"publisher","unstructured":"Celius EG, Ciplea AI, Drulovi\u0107 J, et al. Alemtuzumab and pregnancy\u2014case series from the German MS and Pregnancy Registry, Norway and Serbia. In: Poster Session 2: Poster P915. Mult Scler J. 2018;24:328\u2013529. https:\/\/doi.org\/10.1177\/1352458518798590.","DOI":"10.1177\/1352458518798590"},{"key":"202_CR106","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1212\/WNL.0000000000004207","volume":"89","author":"A Langer-Gould","year":"2017","unstructured":"Langer-Gould A, Smith JB, Hellwig K, et al. Breastfeeding, ovulatory years, and risk of multiple sclerosis. Neurology. 2017;89:563\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000004207.","journal-title":"Neurology"},{"key":"202_CR107","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s13311-017-0562-7","volume":"14","author":"R Voskuhl","year":"2017","unstructured":"Voskuhl R, Momtazee C. Pregnancy: effect on multiple sclerosis, treatment considerations, and breastfeeding. Neurotherapeutics. 2017;14:974\u201384. https:\/\/doi.org\/10.1007\/s13311-017-0562-7.","journal-title":"Neurotherapeutics"},{"key":"202_CR108","first-page":"757","volume":"140","author":"G Khan","year":"1992","unstructured":"Khan G, Coates PJ, Gupta RK, et al. Presence of Epstein\u2013Barr virus in Hodgkin\u2019s disease is not exclusive to Reed-Sternberg cells. Am J Pathol. 1992;140:757\u201362.","journal-title":"Am J Pathol"},{"key":"202_CR109","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/jcp.45.7.616","volume":"45","author":"G Khan","year":"1992","unstructured":"Khan G, Coates PJ, Kangro HO, et al. Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol. 1992;45:616\u201320.","journal-title":"J Clin Pathol"},{"key":"202_CR110","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1002\/1097-0142(19930515)71:10<3124::AID-CNCR2820711038>3.0.CO;2-J","volume":"71","author":"G Khan","year":"1993","unstructured":"Khan G, Norton AJ, Slavin G. Epstein\u2013Barr virus in Hodgkin disease. Relation to age and subtype. Cancer. 1993;71:3124\u20139.","journal-title":"Cancer"},{"key":"202_CR111","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/JCI23661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein\u2013Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest. 2005;115:1352\u201360. https:\/\/doi.org\/10.1172\/JCI23661.","journal-title":"J Clin Invest"},{"key":"202_CR112","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1600-0404.2003.00221.x","volume":"109","author":"S Haahr","year":"2004","unstructured":"Haahr S, Plesner AM, Vestergaard BF, et al. A role of late Epstein\u2013Barr virus infection in multiple sclerosis. Acta Neurol Scand. 2004;109:270\u20135. https:\/\/doi.org\/10.1046\/j.1600-0404.2003.00221.x.","journal-title":"Acta Neurol Scand"},{"key":"202_CR113","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.293.4.463","volume":"293","author":"A-L Ponsonby","year":"2005","unstructured":"Ponsonby A-L, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA. 2005;293:463\u20139. https:\/\/doi.org\/10.1001\/jama.293.4.463.","journal-title":"JAMA"},{"key":"202_CR114","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007;204:2899\u2013912. https:\/\/doi.org\/10.1084\/jem.20071030.","journal-title":"J Exp Med"},{"key":"202_CR115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00415-006-0316-7","volume":"254","author":"ML Opsahl","year":"2007","unstructured":"Opsahl ML, Kennedy PGE. An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue. J Neurol. 2007;254:425\u201330. https:\/\/doi.org\/10.1007\/s00415-006-0316-7.","journal-title":"J Neurol"},{"key":"202_CR116","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ, et al. Epstein\u2013Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain. 2009;132:3318\u201328. https:\/\/doi.org\/10.1093\/brain\/awp200.","journal-title":"Brain"},{"key":"202_CR117","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","volume":"74","author":"SA Sargsyan","year":"2010","unstructured":"Sargsyan SA, Shearer AJ, Ritchie AM, et al. Absence of Epstein\u2013Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. 2010;74:1127\u201335. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d865a1.","journal-title":"Neurology"},{"key":"202_CR118","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1093\/brain\/awq223","volume":"133","author":"F Aloisi","year":"2010","unstructured":"Aloisi F, Serafini B, Magliozzi R, et al. Detection of Epstein\u2013Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain. 2010;133:e157. https:\/\/doi.org\/10.1093\/brain\/awq223.","journal-title":"Brain"},{"key":"202_CR119","doi-asserted-by":"publisher","first-page":"e0192109","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani A, Corboy JR, Al-Salam S, et al. Epstein\u2013Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS ONE. 2018;13:e0192109. https:\/\/doi.org\/10.1371\/journal.pone.0192109.","journal-title":"PLoS ONE"},{"key":"202_CR120","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","volume":"78","author":"JS Tzartos","year":"2012","unstructured":"Tzartos JS, Khan G, Vossenkamper A, et al. Association of innate immune activation with latent Epstein\u2013Barr virus in active MS lesions. Neurology. 2012;78:15\u201323. https:\/\/doi.org\/10.1212\/WNL.0b013e31823ed057.","journal-title":"Neurology"},{"key":"202_CR121","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12985-015-0260-1","volume":"12","author":"G Khan","year":"2015","unstructured":"Khan G, Ahmed W, Philip PS, et al. Healthy rabbits are susceptible to Epstein\u2013Barr virus infection and infected cells proliferate in immunosuppressed animals. Virol J. 2015;12:28. https:\/\/doi.org\/10.1186\/s12985-015-0260-1.","journal-title":"Virol J"},{"key":"202_CR122","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnmol.2018.00164","volume":"11","author":"CM Abreu","year":"2018","unstructured":"Abreu CM, Soares-Dos-Reis R, Melo PN, et al. Emerging biosensing technologies for neuroinflammatory and neurodegenerative disease diagnostics. Front Mol Neurosci. 2018;11:164. https:\/\/doi.org\/10.3389\/fnmol.2018.00164.","journal-title":"Front Mol Neurosci"},{"key":"202_CR123","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1021\/acschemneuro.9b00036","volume":"10","author":"A Cruz","year":"2019","unstructured":"Cruz A, Queiros R, Abreu CM, et al. Electrochemical immunosensor for TNFalpha-mediated inflammatory disease screening. ACS Chem Neurosci. 2019;10:2676\u201382. https:\/\/doi.org\/10.1021\/acschemneuro.9b00036.","journal-title":"ACS Chem Neurosci"},{"key":"202_CR124","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ana.25146","volume":"83","author":"P Maggi","year":"2018","unstructured":"Maggi P, Absinta M, Grammatico M, et al. Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018;83:283\u201394. https:\/\/doi.org\/10.1002\/ana.25146.","journal-title":"Ann Neurol"},{"key":"202_CR125","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","volume":"31","author":"MF Glasser","year":"2011","unstructured":"Glasser MF, Van Essen DC, Manuscript A, et al. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci. 2011;31:11597\u2013616. https:\/\/doi.org\/10.1523\/JNEUROSCI.2180-11.2011.","journal-title":"J Neurosci"},{"key":"202_CR126","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature18933","volume":"536","author":"MF Glasser","year":"2016","unstructured":"Glasser MF, Coalson TS, Robinson EC, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536:171\u20138. https:\/\/doi.org\/10.1038\/nature18933.","journal-title":"Nature"},{"key":"202_CR127","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2017.3880","volume":"75","author":"Y Backner","year":"2018","unstructured":"Backner Y, Kuchling J, Massarwa S, et al. Anatomical wiring and functional networking changes in the visual system following optic neuritis. JAMA Neurol. 2018;75:287\u201395. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3880.","journal-title":"JAMA Neurol"},{"key":"202_CR128","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamaneurol.2017.3890","volume":"75","author":"C Finke","year":"2018","unstructured":"Finke C, Zimmermann H, Pache F, et al. Association of visual impairment in neuromyelitis optica spectrum disorder with visual network reorganization visual network reorganization in neuromyelitis optica spectrum disorder visual network reorganization in neuromyelitis optica spectrum disorder. JAMA Neurol. 2018;75:296\u2013303. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3890.","journal-title":"JAMA Neurol"},{"key":"202_CR129","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","volume":"18","author":"O Ciccarelli","year":"2019","unstructured":"Ciccarelli O, Cohen JA, Reingold SC, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol. 2019;18:185\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(18)30460-5.","journal-title":"Lancet Neurol"},{"key":"202_CR130","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.neuroimage.2018.09.081","volume":"184","author":"C Gros","year":"2019","unstructured":"Gros C, De Leener B, Badji A, et al. Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. Neuroimage. 2019;184:901\u201315. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.09.081.","journal-title":"Neuroimage"},{"key":"202_CR131","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, Balcer LJ, Calabresi PA, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16:797\u2013812. https:\/\/doi.org\/10.1016\/S1474-4422(17)30278-8.","journal-title":"Lancet Neurol"},{"key":"202_CR132","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jamaneurol.2018.1011","volume":"75","author":"HG Zimmermann","year":"2018","unstructured":"Zimmermann HG, Knier B, Oberwahrenbrock T, et al. Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome. JAMA Neurol. 2018;75:1071\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1011.","journal-title":"JAMA Neurol"},{"key":"202_CR133","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","volume":"89","author":"FC Oertel","year":"2018","unstructured":"Oertel FC, Havla J, Roca-Fernandez A, et al. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry. 2018;89:1259\u201365. https:\/\/doi.org\/10.1136\/jnnp-2018-318382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"202_CR134","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","volume":"92","author":"SC Xu","year":"2019","unstructured":"Xu SC, Kardon RH, Leavitt JA, et al. Optical coherence tomography is highly sensitive in detecting prior optic neuritis. Neurology. 2019;92:e527\u2013e535535. https:\/\/doi.org\/10.1212\/WNL.0000000000006873.","journal-title":"Neurology"},{"key":"202_CR135","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.24564","volume":"79","author":"OH Kantarci","year":"2016","unstructured":"Kantarci OH, Lebrun C, Siva A, et al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol. 2016;79:288\u201394. https:\/\/doi.org\/10.1002\/ana.24564.","journal-title":"Ann Neurol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00202-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:23:14Z","timestamp":1712762594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00202-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00202-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}